TFEB and type 2 diabetes mellitus: As expected, 3-MA inhibited ALP function, resulting in decreased ALP activity in T2DM mice (Fig. 4A, B) and HG-cultured HT22 cells (Fig. 5A, B) when used in combination with TFEB overexpression.